BridgePoint Medical is focused on developing innovative and proprietary technology in the field of interventional cardiology for access to and treatment of chronic total occlusions. Peripheral vascular products licensed to Covidien in 2012. Company acquired by Boston Scientific in 2012.  
  ______________________________________________________________________________  
   
  Apnex Medical is focused on pioneering medical innovations to improve the health of people with obstructive sleep apnea. Apnex sold its assets to Cyberonics in 2013.  
  ______________________________________________________________________________  
   
  ClarVista is focused on novel solutions in cataract surgery.  
  ______________________________________________________________________________  
   
  OcuTherix is dedicated to medical device innovation to save vision in people with glaucoma.

 


 
   
___________________________________________________________________
Prospex Medical Home | Management | Portfolio | Contact